Instituto Rosenbusch Statistics
Total Valuation
BCBA:ROSE has a market cap or net worth of ARS 8.73 billion. The enterprise value is 10.46 billion.
| Market Cap | 8.73B |
| Enterprise Value | 10.46B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BCBA:ROSE has 42.59 million shares outstanding.
| Current Share Class | 42.58M |
| Shares Outstanding | 42.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 80.05% |
| Owned by Institutions (%) | n/a |
| Float | 8.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.16 |
| PB Ratio | 13.74 |
| P/TBV Ratio | 23.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.40 |
| EV / Sales | 2.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.61 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 4.09.
| Current Ratio | 1.06 |
| Quick Ratio | 0.49 |
| Debt / Equity | 4.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.88 |
| Interest Coverage | -6.82 |
Financial Efficiency
Return on equity (ROE) is -191.40% and return on invested capital (ROIC) is -107.06%.
| Return on Equity (ROE) | -191.40% |
| Return on Assets (ROA) | -22.00% |
| Return on Invested Capital (ROIC) | -107.06% |
| Return on Capital Employed (ROCE) | -120.59% |
| Weighted Average Cost of Capital (WACC) | 4.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, BCBA:ROSE has paid 64.29 million in taxes.
| Income Tax | 64.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.11% in the last 52 weeks. The beta is -0.26, so BCBA:ROSE's price volatility has been lower than the market average.
| Beta (5Y) | -0.26 |
| 52-Week Price Change | +88.11% |
| 50-Day Moving Average | 232.12 |
| 200-Day Moving Average | 190.17 |
| Relative Strength Index (RSI) | 43.15 |
| Average Volume (20 Days) | 26,659 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BCBA:ROSE had revenue of ARS 4.04 billion and -4.35 billion in losses. Loss per share was -102.16.
| Revenue | 4.04B |
| Gross Profit | -887.22M |
| Operating Income | -2.75B |
| Pretax Income | -4.24B |
| Net Income | -4.35B |
| EBITDA | -2.62B |
| EBIT | -2.75B |
| Loss Per Share | -102.16 |
Balance Sheet
The company has 1.14 billion in cash and 2.60 billion in debt, with a net cash position of -1.46 billion or -34.32 per share.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 2.60B |
| Net Cash | -1.46B |
| Net Cash Per Share | -34.32 |
| Equity (Book Value) | 635.55M |
| Book Value Per Share | 8.75 |
| Working Capital | 361.84M |
Cash Flow
In the last 12 months, operating cash flow was -663.09 million and capital expenditures -6.90 million, giving a free cash flow of -669.99 million.
| Operating Cash Flow | -663.09M |
| Capital Expenditures | -6.90M |
| Free Cash Flow | -669.99M |
| FCF Per Share | -15.73 |
Margins
Gross margin is -21.95%, with operating and profit margins of -67.95% and -107.62%.
| Gross Margin | -21.95% |
| Operating Margin | -67.95% |
| Pretax Margin | -104.95% |
| Profit Margin | -107.62% |
| EBITDA Margin | -64.86% |
| EBIT Margin | -67.95% |
| FCF Margin | n/a |
Dividends & Yields
BCBA:ROSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -49.83% |
| FCF Yield | -7.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 16, 2011. It was a forward split with a ratio of 1.43614361.
| Last Split Date | Nov 16, 2011 |
| Split Type | Forward |
| Split Ratio | 1.43614361 |
Scores
BCBA:ROSE has an Altman Z-Score of -1.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.33 |
| Piotroski F-Score | 1 |